Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT07702955 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07702955
- Sponsor
- Kangabio AUSTRALIA LTD PTY
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-09-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.